Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-015722

Chief Medical Officer acquired 4,374 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Soergel David Chief Medical Officer 2026-03-04 Grant or award +4,374 11,919 D
Derivatives
Soergel David Chief Medical Officer 2026-03-04 Grant or award · Stock Option (Right to Buy) +5,467 5,467 D
Loading xslF345X05/wk-form4_1772837756.xml…